About Corgenix
Corgenix is a company based in Broomfield (United States) founded in 1990 was acquired by Orgentec Diagnostika in August 2014. The company has 24 employees as of December 31, 2022. Corgenix offers products and services including M-inSight® and Diagnostic Solutions. Corgenix operates in a competitive market with competitors including Charles River Laboratories, Cytel, LabCorp, Precision Medicine Group and Frontage Laboratories, among others.
- Headquarter Broomfield, United States
- Employees 24 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
HHS
& 2 more
-
Employee Count
24
as on Dec 31, 2022
-
Acquired by
Orgentec Diagnostika
(Aug 28, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Corgenix
Corgenix offers a comprehensive portfolio of products and services, including M-inSight® and Diagnostic Solutions.
Test for monitoring multiple myeloma patients in clinical settings
Services for clinical studies and trial management support
Funding Insights of Corgenix
Investors in Corgenix
Corgenix has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include HHS, European Union and Orgentec Diagnostika.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Diagnostics tools for Autoimmune and Infectious Diseases
|
Locked | Locked | Locked |
Investor details for Corgenix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Corgenix
Investment portfolio details for Corgenix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Corgenix
Detailed financials for Corgenix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Corgenix Comparisons
Peer comparison for Corgenix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Corgenix
Corgenix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Charles River Laboratories, Cytel, LabCorp, Precision Medicine Group and Frontage Laboratories, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of drug discovery and preclinical development services
|
|
| Locked | Locked | Locked |
Data analysis and statistical solutions are provided for life sciences.
|
|
| Locked | Locked | Locked |
Provider of laboratory tests for physicians
|
|
| Locked | Locked | Locked |
Provider of clinical research, development, and commercialization services for life sciences
|
|
| Locked | Locked | Locked |
Early drug development services are provided for pharma firms.
|
|
| Locked | Locked | Locked |
Genetic and clinical data are integrated for precision cardiac medicines.
|
Detailed competitors of Corgenix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Corgenix
Complete news archive for Corgenix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Corgenix
Corgenix was founded in 1990 and raised its 1st funding round 17 years after it was founded.
Corgenix is headquartered in Broomfield, United States. It is registered at Broomfield, Colorado, United States.
Werner Hofacher is the current CEO of Corgenix.
As of Dec 31, 2022, the latest employee count at Corgenix is 24.
Founded in 1990, Corgenix is headquartered in Broomfield, United States. Focus is placed on the healthcare sector, where in vitro diagnostic tests for vascular diseases are created and distributed. Operations involve research, manufacturing, and commercialization of these medical products to support clinical applications. Leadership is provided by CEO Werner Hofacher, with activities centered in the United States market.
Corgenix's top competitors include LabCorp, Charles River Laboratories and Cytel.
Corgenix offers M-inSight® and Diagnostic Solutions.
Corgenix has 3 investors. Key investors include HHS, European Union, and Orgentec Diagnostika.